[#item_full_content] The Drug Enforcement Administration (DEA) has issued new guidance warning that medical marijuana businesses that want to receive federal registration and protections under the Trump administration’s rescheduling reform have until late November to begin sourcing cannabis only from and to other companies that have also been granted or applied for registration in a timely fashion.  Read More